Abstract:Adaptive designs can make clinical trials more flexible by utilising results accumulating in the trial to modify the trial’s course in accordance with pre-specified rules. Trials with an adaptive design are often more efficient, informative and ethical than trials with a traditional fixed design since they often make better use of resources such as time and money, and might require fewer participants. Adaptive designs can be applied across all phases of clinical research, from early-phase dose escalation to confirmatory trials. The pace of the uptake of adaptive designs in clinical research, however, has remained well behind that of the statistical literature introducing new methods and highlighting their potential advantages. We speculate that one factor contributing to this is that the full range of adaptations available to trial designs, as well as their goals, advantages and limitations, remains unfamiliar to many parts of the clinical community. Additionally, the term adaptive design has been misleadingly used as an all-encompassing label to refer to certain methods that could be deemed controversial or that have been inadequately implemented.We believe that even if the planning and analysis of a trial is undertaken by an expert statistician, it is essential that the investigators understand the implications of using an adaptive design, for example, what the practical challenges are, what can (and cannot) be inferred from the results of such a trial, and how to report and communicate the results. This tutorial paper provides guidance on key aspects of adaptive designs that are relevant to clinical triallists. We explain the basic rationale behind adaptive designs, clarify ambiguous terminology and summarise the utility and pitfalls of adaptive designs. We discuss practical aspects around funding, ethical approval, treatment supply and communication with stakeholders and trial participants. Our focus, however, is on the interpretation and reporting of results from adaptive design trials, which we consider vital for anyone involved in medical research. We emphasise the general principles of transparency and reproducibility and suggest how best to put them into practice.

Adaptive Designs for Sequential Experiments

ASYMPTOTIC PROPERTIES OF ADAPTIVE DESIGNS VIA STRONG APPROXIMATIONS

Adaptive Allocation Theory in Clinical Trials

Doubly Adaptive Biased Coin Designs with Delayed Responses

The asymptotic theorems of adaptive designs for clinical trials with generations depending on the estimated success rates

Efficient Randomized-Adaptive Designs

Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials

Asymptotic Results on a Class of Adaptive Multi-Treatment Designs

An Adaptive Trial Design to Optimize Dose-Schedule Regimes with Delayed Outcomes

Adaptive Experimental Design: Prospects and Applications in Political Science

Adaptive designs in clinical trials: why use them, and how to run and report them

Adaptive two-stage seamless sequential design for clinical trials

Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs

New designs for Bayesian adaptive cluster-randomized trials

Deep Adaptive Design: Amortizing Sequential Bayesian Experimental Design

Adaptive designs in clinical trials: a systematic review-part I

A New Adaptive Design Based on Simon's Two-Stage Optimal Design for Phase II Clinical Trials.

Optimal Adaptive Experimental Design for Estimating Treatment Effect

A New Family of Covariate-Adjusted Response Adaptive Designs and Their Properties

Point estimation, confidence intervals, and P‐values for optimal adaptive two‐stage designs with normal endpoints

Central Limit Theorems of a Recursive Stochastic Algorithm with Applications to Adaptive Designs